-
1
-
2
-
3
-
4
-
5
A phase 1b, open-label, two-part safety, tolerability, and efficacy study of a soluble beta-glucan (odetiglucan) in combination with a CD40 agonistic monoclonal antibody (CDX-1140) in patients with metastatic pancreatic adenocarcinoma whose disease did not progress during first-line (1L) chemotherapy
Veröffentlicht in Journal of clinical oncology
VolltextArtikel -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Mycochemicals in wild and cultivated mushrooms: nutrition and health
Veröffentlicht in Phytochemistry reviews
VolltextArtikel -
14
-
15
-
16
-
17
-
18
-
19
GA4GH Phenopackets: A Practical Introduction
Veröffentlicht in Genetics & genomics next
VolltextArtikel -
20